Preparation and Evaluation of Mouth Dissolving Tablet of Albendazole Using Different Concentrations of Super-Disintegrant

Kedar Rupa Bavaskar, Supriya Pote, Prasad Vidhate, Vinit Patil, Ashish Jain

Abstract


Anthelmintic medications are anticipated to act more quickly and have greater absorption. Mouth-dissolving albendazole tablets were created using a direct compression approach and a mixture of super disintegrants to accomplish rapid disintegration of the tablets in the oral cavity. The preparation of ten batches of mouth-dissolving tablets using different grades of Kollidon, crospovidone, sodium starch glycolate, and croscarmellose sodium as super disintegrants produced the greatest results. For a compatibility investigation, FTIR was used to characterize the drug and physical mixture. An optimization technique was used to forecast the most effective formulation out of all the prepared combinations. All the physical characteristics of the tablet are within the limit. All preformulation results indicated good flow properties. Disintegration time and drug content of the F4 batch were found to be 28 seconds and 95.69%, respectively. In vitro release of the drug was performed in a phosphorus buffer pH 6.8 for 40 min, in which F4 shows maximum drug release. Based on the stability studies, it was confirmed that the optimized formulation remained at accelerated stability conditions. It was discovered that the mouth-dissolving tablet exhibits effective drug release.

Keywords


albendazole; dissolution; direct compression; kolidon; tablet

Full Text:

PDF

References


Bremmell KE, Prestidge CA. Enhancing oral bioavailability of poorly soluble drugs with mesoporous silica-based systems: opportunities and challenges. Drug Dev Ind Pharm. 2019;45(3):349–58. http://dx.doi.org/10.1080/03639045.2018.1542709

Mekasha YT. Pharmaceutical solid oral dosage form analysis: Literature review. Open Access Journal of Biogeneric Science and Research. 2020;4(1).http://dx.doi.org/10.46718/jbgsr.2020.04.000087

Gaikwad SS, Kshirsagar SJ. Review on tablet in tablet techniques. Beni-Suef Univ J Basic Appl Sci. 2020;9(1). http://dx.doi.org/10.1186/s43088-019-0027-7

Hannan PA, Khan JA, Khan A, Safiullah S. Oral dispersible system: A new approach in drug delivery system. Indian J Pharm Sci. 2016;78(1):2. http://dx.doi.org/10.4103/0250-474x.180244

Radhakrishnan C, Sefidani Forough A, Cichero JAY, Smyth HE, Raidhan A, Nissen LM, et al. A difficult pill to swallow: An investigation of the factors associated with medication swallowing difficulties. Patient Prefer Adherence. 2021;15:29–40. http://dx.doi.org/10.2147/ppa.s277238

Chauhan V, Global Institute of Pharmaceutical Education and Research, Kashipur, Uttarakhand, India. Fast dissolving tablets: A promising approach for drug delivery. Univers J Pharm Res. 2017;2(4):58–64. http://dx.doi.org/10.22270/ujpr.v2i4.rw4

Sitre DG, Kamble RK. Formulation development and evaluation of new Albendazole tablets with integrated quality by design (QbD) approach. J Drug Deliv Ther. 2021;11(2):123–34. http://dx.doi.org/10.22270/jddt.v11i2.4782

Hong S-T. Albendazole and praziquantel: Review and safety monitoring in Korea. Infect Chemother. 2018;50(1):1. http://dx.doi.org/10.3947/ic.2018.50.1.1

Rane DR, Gulve HN, Patil VV, Thakare VM, Patil VR. Formulation and evaluation of fast dissolving tablet of albendazole. Int Curr Pharm J.2012;1(10):311–6. http://dx.doi.org/10.3329/icpj.v1i10.11848

Ljubas D, Čizmić M, Vrbat K, Stipaničev D, Repec S, Ćurković L, et al. Albendazole degradation possibilities by UV-based advanced oxidation processes. Int J Photoenergy. 2018;2018:1–6. http://dx.doi.org/10.1155/2018/6181747

Dwivedi A, Darwhekar GN. Research paper Design, Optimization and Evaluation of Empagliflozin Orodispersible Tablets Using Differentsuperdisintegrants. Int J Pharm Pharm Sci. 2019;32–41.http://dx.doi.org/10.22159/ijpps.2019v11i7.33213

Mustafa MA, Saif ur Rehman N, Majeed Khan A, Munir M, Azhar K, Ahmed F, et al. Formulation and in vitro evaluation of natural polymer based albendazole gummies: A novel pediatrics dosage form. J Young Pharm. 2023;15(3):478–84. http://dx.doi.org/10.5530/jyp.2023.15.63

Nelson E. A note on tablet hardness. J Am Pharm Assoc (Sci). 1956;45(5):354–5. http://dx.doi.org/10.1002/jps.3030450526

Osei-Yeboah F, Sun CC. Validation and applications of an expedited tablet friability method. Int J Pharm. 2015;484(1–2):146–55. http://dx.doi.org/10.1016/j.ijpharm.2015.02.061

Hitendra S M. Development and evaluation of rutin-HPβCD inclusion complex based mouth dissolving tablets. Int J Pharm Sci Dev Res. 2018;001–6. http://dx.doi.org/10.17352/ijpsdr.000009

Hamishehkar H, Ghanbarzadeh S, Khalili A, Jouyban A, Emami S, Javadzadeh Y, et al. Dramatic improvement in dissolution rate of albendazole by a simple, one-step, industrially scalable technique. Res Pharm Sci.2016;11(6):435. http://dx.doi.org/10.4103/1735-5362.194868

Belew S, Getachew M, Suleman S, Mohammed T, Deti H, D’Hondt M, et al. Assessment of efficacy and quality of two albendazole brands commonly used against soil-transmitted helminth infections in school children in Jimma town, Ethiopia. PLoS Negl Trop Dis. 2015;9(9):e0004057. http://dx.doi.org/10.1371/journal.pntd.0004057

Solubility enhancement of nimodipine through preparation of Soluplus® dispersions. J Appl Pharm Sci. 2019;9(9):30–7. http://dx.doi.org/10.7324/japs.2019.90905

Sapkal S. Babhulkar M. Rathi A. Mehetre G. Narkhede M. An Overview on The Mechanisms of Solubility and Dissolution Rate Enhancement In Solid Dispersion. Int. J. Pharm Tech. Res. 2013, 5(1), 31-39 https://doi.org/10.7324/japs.2019.90905

Joshi S, Dubey I, Bilaiya A, Yadav K, Dorwal D, Aditya Parashar AP. A practical approach for solubility enhancement of Albendazole. Orient J Chem. 2022;38(1):215–8. http://dx.doi.org/10.13005/ojc/380129




DOI: https://doi.org/10.18196/jfaps.v4i2.19148

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.


Journal of Fundamental and Applied Pharmaceutical Science are indexed by:

       

Office:

K.H. Sudja Building G3, 2nd Floor, Faculty of Medicine and Health Science, Universitas Muhammadiyah Yogyakarta,
Jalan Brawijaya (Lingkar Selatan), Tamantirto, Kasihan, Bantul, Daerah Istimewa Yogyakarta.
Whatsapp: +62 822-2155-6698
Email: jfaps@umy.university
Website: http://journal.umy.ac.id/index.php/jfap/index

Creative Commons License

Journal of Fundamental and Applied Pharmaceutical Science is licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license.